Kurt von Emster's most recent trade in Jasper Therapeutics Inc was a trade of 7,500 Stock Option (right to buy) done . Disclosure was reported to the exchange on July 3, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Jasper Therapeutics Inc | Kurt von Emster | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jul 2025 | 7,500 | 7,500 | - | - | Stock Option (right to buy) | |
| Jasper Therapeutics Inc | Kurt von Emster | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jun 2024 | 7,500 | 7,500 | - | - | Stock Option (right to buy) | |
| Cymabay Therapeutics Inc | Kurt von Emster | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 22 Mar 2024 | 90,000 | 0 (0%) | 0% | - | Common Stock | |
| Cymabay Therapeutics Inc | Kurt von Emster | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 22 Mar 2024 | 67,000 | 0 | - | - | Employee Stock Option (right to buy) | |
| Cymabay Therapeutics Inc | Kurt von Emster | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 22 Mar 2024 | 49,245 | 0 | - | - | Employee Stock Option (right to buy) | |
| Cymabay Therapeutics Inc | Kurt von Emster | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 22 Mar 2024 | 32,000 | 0 | - | - | Employee Stock Option (right to buy) | |
| Cymabay Therapeutics Inc | Kurt von Emster | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 22 Mar 2024 | 27,705 | 0 | - | - | Employee Stock Option (right to buy) | |
| Cymabay Therapeutics Inc | Kurt von Emster | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 22 Mar 2024 | 25,000 | 0 | - | - | Employee Stock Option (right to buy) | |
| Cymabay Therapeutics Inc | Kurt von Emster | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 22 Mar 2024 | 16,000 | 0 | - | - | Employee Stock Option (right to buy) | |
| Cymabay Therapeutics Inc | Kurt von Emster | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 22 Mar 2024 | 15,000 | 0 | - | - | Employee Stock Option (right to buy) | |
| Cymabay Therapeutics Inc | Kurt von Emster | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 22 Mar 2024 | 14,010 | 0 | - | - | Employee Stock Option (right to buy) | |
| Cymabay Therapeutics Inc | Kurt von Emster | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 22 Mar 2024 | 9,000 | 0 | - | - | Employee Stock Option (right to buy) | |
| Cymabay Therapeutics Inc | Kurt von Emster | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 22 Mar 2024 | 9,000 | 0 | - | - | Employee Stock Option (right to buy) | |
| Cymabay Therapeutics Inc | Kurt von Emster | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 22 Mar 2024 | 9,000 | 0 | - | - | Employee Stock Option (right to buy) | |
| Cymabay Therapeutics Inc | Kurt von Emster | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 22 Mar 2024 | 7,500 | 0 | - | - | Employee Stock Option (right to buy) | |
| Cymabay Therapeutics Inc | von Emster Kurt | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Jan 2024 | 14,010 | 14,010 | - | - | Stock Option (right to buy) | |
| Jasper Therapeutics Inc | Kurt von Emster | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jun 2023 | 47,000 | 47,000 | - | - | Stock Option (right to buy) | |
| Jasper Therapeutics Inc | Kurt von Emster | Director | Sale of securities on an exchange or to another person at price $ 1.49 per share. | 13 Apr 2023 | 9,075 | 21,175 | - | 1.5 | 13,524 | Voting Common Stock |
| Cymabay Therapeutics Inc | Kurt von Emster | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Jan 2023 | 25,000 | 25,000 | - | - | Stock Option (right to buy) | |
| Jasper Therapeutics Inc | Kurt von Emster | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Oct 2022 | 30,250 | 30,250 | - | 0 | Voting Common Stock | |
| Jasper Therapeutics Inc | Kurt von Emster | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Mar 2022 | 78,045 | 78,045 | - | - | Stock Option (right to buy) | |
| Cymabay Therapeutics Inc | Kurt von Emster | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Jan 2022 | 67,000 | 67,000 | - | - | Stock Option (right to buy) | |
| Vaxcyte Inc | Kurt von Emster | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jun 2021 | 15,000 | 15,000 | - | - | Stock option (right to buy) | |
| Cymabay Therapeutics Inc | Kurt von Emster | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Jan 2021 | 32,000 | 32,000 | - | - | Stock Option (right to buy) |